Macquarie Group LTD Athersys, Inc Transaction History

Macquarie Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$0.85 - $1.4 $4,731 - $7,792	-5,566 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$1.61 - $2.77 $2,748 - $4,728	-1,707 Reduced 23.47%	5,566 $10,000
Q2 2020 Aug 11, 2020	BUY	$1.97 - $3.98 $14,327 - $28,946	7,273 New	7,273 $20,000
Q1 2018 May 11, 2018	SELL	$1.34 - $2.03 $6,298 - $9,540	-4,700 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$1.65 - $2.45 $7,755 - $11,515	4,700	4,700 $9,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.